UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057775 |
|---|---|
| Receipt number | R000066029 |
| Scientific Title | Histological diagnosis and treatment of transurethral resection of bladder tumor for bladder cancer. |
| Date of disclosure of the study information | 2025/06/01 |
| Last modified on | 2025/05/04 20:26:58 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Histological diagnosis and treatment of transurethral resection of bladder tumor for bladder cancer.
Acronym
Histological diagnosis and treatment of transurethral resection of bladder tumor for bladder cancer.
Scientific Title
Histological diagnosis and treatment of transurethral resection of bladder tumor for bladder cancer.
Scientific Title:Acronym
Histological diagnosis and treatment of transurethral resection of bladder tumor for bladder cancer.
Region
| Japan |
Condition
Condition
bladder cancer
Classification by specialty
| Urology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to retrospectively review TURBT cases for bladder cancer at our institution and to discuss the outcomes, complications, and pathologic diagnosis of TURBT.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Comparison of histopathological diagnosis and prognosis of specimens obtained by transurethral surgery (conventional and en bloc resection) for bladder cancer.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 99 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Patients undergoing transurethral cystectomy for bladder cancer
Key exclusion criteria
Patients who have expressed their refusal to participate in this study through a release of information document
Target sample size
400
Research contact person
Name of lead principal investigator
| 1st name | YOHEI |
| Middle name | |
| Last name | OKADA |
Organization
Saitama Medical Center, Saitama Medical University
Division name
Department of Urology
Zip code
350-8550
Address
Kamoda 1981, Kawagoe, Saitama
TEL
049-228-3673
okada@saitama-med.ac.jp
Public contact
Name of contact person
| 1st name | YOHEI |
| Middle name | |
| Last name | OKADA |
Organization
Saitama Medical Center, Saitama Medical University
Division name
Department of Urology
Zip code
350-8550
Address
Kamoda1981, Kawagoe, Saitama
TEL
049-228-3673
Homepage URL
okada@saitama-med.ac.jp
Sponsor or person
Institute
Saitama Medical University
Institute
Department
Personal name
Funding Source
Organization
Saitama Medical University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Saitama Medical Center, Saitama Medical University
Address
Kamoda 1981, Kawagoe, Saitama
Tel
049-228-3673
okada@saitama-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 06 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
400
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2010 | Year | 01 | Month | 01 | Day |
Date of IRB
| 2024 | Year | 11 | Month | 07 | Day |
Anticipated trial start date
| 2010 | Year | 01 | Month | 01 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
TURBT is an essential surgical treatment for bladder cancer and plays a role in diagnosing the stage and grade of cancer. It is expected that obtaining clinical data of TURBT close to actual clinical practice will lead to safer and more accurate bladder cancer treatment.
Management information
Registered date
| 2025 | Year | 05 | Month | 04 | Day |
Last modified on
| 2025 | Year | 05 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066029
